Dr. John J Kownacki, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 680 Fletcher Pkwy Ste 202, El Cajon, CA 92020 Phone: 619-440-2022 Fax: 619-440-2466 |
Frank Stephen Kohl, Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2397 Cerro Sereno, El Cajon, CA 92019 Phone: 619-820-5842 Fax: 619-447-5990 |
Dr. Franklin Allen Crystal, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 225 W Madison Ave, Suite 1, El Cajon, CA 92020 Phone: 619-442-0844 Fax: 619-442-7399 |
Dr. Richard Norman Learn, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 225 West Madison Ave, Suite 1, El Cajon, CA 92020 Phone: 619-442-0844 Fax: 619-442-7399 |
Tailun Zhao, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 450 Fletcher Pkwy Ste 112, El Cajon, CA 92020 Phone: 800-898-2020 Fax: 844-897-3788 |
Mr. Douglas G Miller, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 225 W Madison Avenue, Ste 2, El Cajon, CA 92020 Phone: 619-442-3937 Fax: 619-441-0539 |
News Archive
Women with a family history of breast cancer appear to have a lower risk of developing the disease before menopause if they have ever breastfed a child, according to a report in the August 10/24 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
MSD, known as Merck in the United States and Canada, announced today that final results from the two pivotal Phase III studies of VICTRELIS, its investigational oral hepatitis C protease inhibitor, will be published in the March 31st edition of The New England Journal of Medicine.
Current research indicates that at some point in their life up to 84% of people will be exposed to some form of traumatic event. Although effective post-traumatic stress disorder treatments have been - and continue to be - developed, there remains a lack in relevant research pertaining to the prevention of PTSD.
Hemangiomas - strawberry-like birthmarks that commonly develop in early infancy - are generally harmless, but up to 10 percent cause tissue distortion or destruction and sometimes obstruction of vision or breathing. Since the 1960s, problematic hemangiomas have been treated with corticosteroids such as dexamethasone or prednisone.
Samaritan Pharmaceuticals, a biopharmaceutical company committed to commercializing new innovative therapeutic drugs, has received notification that the claims in the patent application for "Neuroprotective Spirostenol Pharmaceutical Compositions" covering Caprospinol (SP-233) have been allowed by the Australian Patent Office.
› Verified 8 days ago